Taliban Official Announces Group Will Rule Afghanistan with Sharia Law and ‘No Democratic System’
Sharia Law is triumphant in Afghanistan and democracy is dead.
Although leaders of the Taliban are making up some pieces of how they will govern the conquered country as they go along, those are the foundational principles, according to Reuters.
“There will be no democratic system at all because it does not have any base in our country,” senior Taliban leader Waheedullah Hashimi told the outlet.
“We will not discuss what type of political system should we apply in Afghanistan because it is clear. It is Sharia Law and that is it.”
Sharia Law is a strict code of behavior supported by some Muslims.
Taliban officials have tried to present a softer side to the world in the aftermath of their victory.
“We assure the international community that there will be no discrimination against women, but, of course, within the frameworks we have,” spokesman Zabiullah Mujahid said Tuesday, according to The Washington Post.
Since taking power, the Taliban has tried to put a gloss on its image to the extent where one CNN reporter characterized a group of Taliban fighters as seemingly “friendly.”
“The entire world now recognizes that the Taliban are the real rulers of the country,” said Mawlawi Abdulhaq Hemad, a member of the organization’s media team, according to The New York Times. “I am still astonished that people are afraid of Taliban.”
A spokesman for the United Nations’ high commissioner for human rights, Rupert Colville, expressed skepticism about what the words actually mean.
“Such promises will need to be honored, and for the time being — again understandably, given past history — these declarations have been greeted with some skepticism,” he told The Associated Press. “There have been many hard-won advances in human rights over the past two decades. The rights of all Afghans must be defended.”
For example, Fox News reported Thursday that the Taliban “killed a woman in Takhar province after she went out in public without a burqa.”
According to Aliya Kazimy, 27, of Mazar-i-Sharif, women who went shopping alone were told they had to go home and return with men as chaperones.
“I am from the generation that had a lot of opportunities after the fall of the Taliban 20 years ago,” she told the Times.
“I was able to achieve my goals of studying, and for a year I’ve been a university professor, and now my future is dark and uncertain. All these years of working hard and dreaming were for nothing. And the little girls who are just starting out, what future awaits them?” she said.
Hashimi indicated to Reuters that Afghanistan would likely be run by a ruling council, while the group’s supreme leader, Haibatullah Akhundzada, would keep overall control.
When the Taliban previously ruled the country from 1996 to 2001, it had a council making day-to-day decisions, according to the Post.
Advanced Weapons Developer D.A.R.P.A. Invested $25M in Moderna’s mRNA Vax in 2013
The U.S. Defense Advanced Research Projects Agency (DARPA) awarded the gene-based vaccine developer $25.3 million “to research and develop its messenger RNA therapeutics” nearly 8 years ago.
QUICK FACTS:
- An October 2013 press release from Moderna, Inc.—the Covid-19 mRNA vaccine developer—reveals that the pharmaceutical and biotech company was granted over $25 million from DARPA.
- DARPA is a military weapons technology research and development agency for the United States Department of Defense (DOD).
- In 2019, just months before the Covid-19 outbreak, a project DARPA had funded at Moderna demonstrated in a Phase 1 clinical trial that RNA could deliver an antibody to humans and provide protection against the mosquito-borne virus chikungunya, according to The Washington Post.
WHAT THE PRESS RELEASE SAID:
- “Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unknown emerging infectious diseases and engineered biological threats,” the news release stated.
- Moderna noted its company’s ability “to speed the development and manufacture” the vaccine.
- “We are honored to be chosen by DARPA for this important grant, which will greatly accelerate our efforts to develop antibody messenger RNA therapeutics™ to combat a wide range of infectious diseases,” said president and founding CEO of Moderna Stéphane Bancel.
- Bancel said he looked “forward to further expanding the development of our platform into this critically important new therapeutic area.”
WHAT THE $25 MILLION WAS FOR:
- $24.6 million would support research “for up to 5 years,” notes the release.
- This research would “advance promising antibody-producing drug candidates” for “preclinical testing and human clinical trials.”
- Moderna also received a $0.7 million “seedling” grant from DARPA in March to begin work on the project, according to the release.
WHAT IS DARPA?:
- DARPA was launched in 1958 by president Dwight Eisenhower in response to the Soviet Union’s 1957 launch of Sputnik, the first artificial satellite.
- DARPA spends about $3.5 billion a year, focusing “on the Nation’s military Services” in order “to create new strategic opportunities and novel tactical options,” according to DARPA’s website.
- DARPA’s best-known investments include research on the first global satellite-navigation system (known as Transit), stealth aircraft, and the Internet’s precursor, ARPANET, according to Nature.
- The agency has a “reputation for taking on riskier ideas and having a higher tolerance for failure than conventional funding agencies,” Nature adds.
- World leaders characterize agencies like DARPA as “high-risk.”
BACKGROUND:
- In April 2021, DNA Script—a bio-engineering company on human DNA—announced its new partnership with Moderna and its being awarded $5 million from DARPA.
- DNA Script will help DARPA “to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency’s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program,” according to their press release.
- DARPA also awarded Pfizer Inc.—another Covid-19 mRNA vaccine developer—a $7.7 million research contract in December 2013.
- In January of 2015, Moderna announced its partnership with AstraZeneca—yet another Covid-19 vaccine developer—along with its raising $450 million in new funding, according to another press release. “Together with partners AstraZeneca, Alexion, and DARPA (The Defense Advanced Research Projects Agency), Moderna is in active development of 45 preclinical programs in oncology, cardiovascular disease, rare diseases, and infectious diseases,” read the statement.
Jon Fleetwood is Managing Editor for American Faith.


